Khaled Musallam/LinkedIn
Sep 2, 2026, 14:28
Khaled Musallam: The 5th MENA Congress for Rare Diseases Is Coming to Abu Dhabi
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“Looking forward to the 5th MENA Congress for Rare Diseases, taking place 3–5 September in Abu Dhabi.
Pleased to contribute across three exciting areas – chairing the 2nd MENA Summit for Gene and Cell Therapy, chairing and speaking in the rare immune and blood disorders session, and chairing AI, research, and innovation in rare diseases.
Three days bringing together science, innovation, and collaboration to advance care for people living with rare diseases.”
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge